Lonza Group (OTCMKTS:LZAGY) Upgraded by The Goldman Sachs Group to “Strong-Buy”

The Goldman Sachs Group upgraded shares of Lonza Group (OTCMKTS:LZAGY) to a strong-buy rating in a report published on Wednesday morning, Zacks.com reports.

Separately, Berenberg Bank raised Lonza Group to a strong-buy rating in a report on Sunday, June 23rd.

Lonza Group Trading Down 1.7 %

Shares of LZAGY opened at $60.77 on Wednesday. The firm has a 50-day moving average price of $63.96 and a 200 day moving average price of $59.53. Lonza Group has a 52-week low of $34.19 and a 52-week high of $67.00.

Lonza Group Company Profile

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing.